The Effect of Patient-Controlled TEAS vs Sham TEAS for Improve Quality of Life in Patients With Cancer Pain

Launched by YI LIANG · Dec 18, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at a treatment called Patient-Controlled TEAS (PC-TEAS) to see if it can help improve the quality of life for patients who are experiencing pain from cancer. The goal is to determine if this method is feasible and effective before moving on to larger studies. Patients who are eligible to participate are those aged 18 to 75 who have cancer pain with a pain score of 4 or higher, are expected to live for at least six more months, and can communicate clearly about their pain.

Participants will have the chance to use PC-TEAS, which allows them to control their own treatment. They will be asked to help researchers assess how well this treatment works for managing their pain. It’s important to note that people with certain health conditions, such as severe heart or lung problems, or those who are pregnant, cannot take part in this study. This trial is not yet recruiting participants, but it aims to gather important information that could lead to better treatments for cancer pain in the future.

Gender

ALL

Eligibility criteria

• • Participants who had been diagnosed with cancer pain were eligible if they ①were 18 to 75 years old, ②had NRS pain score of ≥4 in the previous 1 week, or had regular use of analgesics, ③ anticipated survival of at least 6 months, ④ECOG-PS score ≤2 points, ⑤stable vital signs, clear consciousness, and the ability to correctly judge their pain, communication is unhindered, able to cooperate with researchers to complete relevant research assessments, ⑥voluntarily participate in this study and sign the informed consent form. Exclusion criteria included the following: ①Have venous thrombosis of the upper and lower limbs (below the elbow/knee joint), active cerebrovascular disease, severe cardiopulmonary dysfunction, or patient is clinically unstable (eg, acute infections, electrolyte disturbances).②Patients with pacemaker implantation or metal implantation in the body. ③People with local skin at acupoints lesions, poor skin conditions, or other people unsuitable for PC-TEAS treatment. ④Cancer patients who are planning to become pregnant recently or are pregnant. ⑤Have a psychiatric disorder or severe cognitive impairment who are unable to communicate. ⑥Participating in other clinical trials.